Currently in the last leg of wave B, waiting for 1580 from current levels and from there 1650. Will go short after it gives reversal candle on daily chart.
Current wave count says we broke out of the triangle and right now we ended wave 3 of the final leg. I am waiting for a retracement till 1580 for wave 4 and then wave 5 till 1650 levels and go short from there. 1650 wont necessarily be the exact level but the point is to short from there after market gives reversal candle on daily time frame.
After a period of good upward momentum, Divi has been consolidating in a range & established support confirmations. A long entry above today Dec 31st high could lead to good upsides..
Among the Pharma majors, DivisLab has been the foremost one to show the change in trend since price crossed 200 DMA and 50 Crossed 200 DMA (Golden Cross). After a jerky rise, price has started correcting due to Negative Divergence. Now the stock is taking support at 200 DMA (1035). But technical support lies at 1011 maximum where bulls are selling PUTs. So this...
Ascendance of US President Trump to throne numbed the Indian Pharma industry (and also IT sector). For last 4-5 years US FDA's (US is one of the most lucrative markets for Indian Pharma) onsite scrutiny and warnings are making it difficult for this manufacturing sector to work. Stocks of big companies nosedived (for example: Wockhardt, Lupin, Auropharma,...
Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. The Company's geographical segments include India (Sales to customers within India) and other countries (Sales to customers outside India). Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers. The Company develops carotenoids, such as Apocarotenal, Betacarotene, Lycopene, Astaxanthin and Canthaxanthin. It manufactures tert-butoxycarbonyl (BOC), Fluorenylmethyloxycarbonyl (FMOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap. The Company exports its products to European and the American countries. Its manufacturing and research and development facilities are located in the State of Andhra Pradesh and Telangana in India.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
DIVISLAB
